Beta
Statins (e.g. atorvastatin, simvastatin, rosuvastatin)
medication Under reviewStatins are a class of prescription lipid-lowering medications that includes atorvastatin, simvastatin, rosuvastatin, and others. They work by inhibiting HMG-CoA reductase, a key enzyme involved in cholesterol synthesis, which lowers LDL cholesterol and reduces the risk of atherosclerotic cardiovascular events. In healthy people, statins are not generally used as a routine supplement; they are medical therapies primarily prescribed for cardiovascular risk reduction rather than general wellness. Different statins vary in potency, dosing, metabolism, and side-effect profiles. Atorvastatin and rosuvastatin are among the more potent options, while simvastatin is often used at lower to moderate intensity. Their general health applications are centered on cholesterol lowering, prevention of heart attack and stroke in appropriate patients, and sometimes reduction of inflammation markers; however, these are medication effects rather than benefits for otherwise healthy adults seeking supplementation.
Research summary
Human evidence shows that statins reliably lower LDL cholesterol and reduce cardiovascular risk, with rosuvastatin, atorvastatin, and simvastatin all having strong clinical evidence for lipid lowering. Comparative trials and meta-analyses suggest broadly similar efficacy across the class at appropriately matched doses, while tolerability differs somewhat by agent and dose. In head-to-head analyses, simvastatin and pravastatin tend to be better tolerated than atorvastatin, and rosuvastatin is often more potent for LDL lowering than atorvastatin or simvastatin. In healthy human subjects, adverse effects are generally uncommon but can include muscle symptoms and liver enzyme elevations, with higher doses increasing risk. Some large human studies also report a small increased risk of new-onset diabetes with certain statins, particularly rosuvastatin relative to atorvastatin in some populations. Overall, the research consensus is that statins are effective and generally safe when medically indicated, but they are not a general-purpose supplement.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Statins (e.g. atorvastatin, simvastatin, rosuvastatin) to your stack to report effects
Comparative efficacy and safety among high-intensity statins: a systematic review and meta-analysis
Becaris publishing review authors
Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice.
Kapur NK, et al.
Long-term effectiveness and safety of rosuvastatin versus atorvastatin in patients with coronary artery disease
Lee KH, et al.
No reports yet
Be the first to report this effect and help the community.
Add Statins (e.g. atorvastatin, simvastatin, rosuvastatin) to your stack to report effects
Comparative efficacy and safety among high-intensity statins: a systematic review and meta-analysis
Becaris publishing review authors
Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice.
Kapur NK, et al.
Long-term effectiveness and safety of rosuvastatin versus atorvastatin in patients with coronary artery disease
Lee KH, et al.
No reports yet
Be the first to report this effect and help the community.
Add Statins (e.g. atorvastatin, simvastatin, rosuvastatin) to your stack to report effects
Long-term effectiveness and safety of rosuvastatin versus atorvastatin in patients with coronary artery disease
Lee KH, et al.
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Statins (e.g. atorvastatin, simvastatin, rosuvastatin) to your stack to report effects
Comparative efficacy and safety among high-intensity statins: a systematic review and meta-analysis
Becaris publishing review authors
Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
Ray KK, Buring JE, Ridker PM
No reports yet
Be the first to report this effect and help the community.
Add Statins (e.g. atorvastatin, simvastatin, rosuvastatin) to your stack to report effects
Long-term effectiveness and safety of rosuvastatin versus atorvastatin in patients with coronary artery disease
Lee KH, et al.
No reports yet
Be the first to report this effect and help the community.
Add Statins (e.g. atorvastatin, simvastatin, rosuvastatin) to your stack to report effects
Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
Ray KK, Buring JE, Ridker PM
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Coronary artery disease or other cardiac conditions
Long-term effectiveness and safety of rosuvastatin versus atorvastatin in patients with coronary artery disease
Lee KH, et al.
Elevated LDL cholesterol or total cholesterol levels
Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice.
Kapur NK, et al.
Long-term effectiveness and safety of rosuvastatin versus atorvastatin in patients with coronary artery disease
Lee KH, et al.
Comparative efficacy and safety among high-intensity statins: a systematic review and meta-analysis
Becaris publishing review authors
May Worsen
Metabolic disorder characterized by high blood sugar and insulin resistance
Long-term effectiveness and safety of rosuvastatin versus atorvastatin in patients with coronary artery disease
Lee KH, et al.
Research (4 studies)
Long-term effectiveness and safety of rosuvastatin versus atorvastatin in patients with coronary artery disease
Lee KH, et al.
Comparative efficacy and safety among high-intensity statins: a systematic review and meta-analysis
Becaris publishing review authors
Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
Ray KK, Buring JE, Ridker PM
Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice.
Kapur NK, et al.
Community updates
No updates yet for this supplement.
Be the first to share your experience!